مورد إلكتروني
أعرض في EDS

Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: a pooled analysis of 20 prospective cohort studies.

التفاصيل البيبلوغرافية
العنوان: Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: a pooled analysis of 20 prospective cohort studies.
بيانات النشر: Springer Science and Business Media B.V. Netherlands 2021-03-27
تفاصيل مُضافة: Sinha R.
Rohan T.E.
Sawada N.
Schouten L.J.
Stolzenberg-Solomon R.Z.
Teras L.R.
Tsugane S.
Visvanathan K.
Weiderpass E.
White K.K.
Willett W.C.
Wolk A.
Zeleniuch-Jacquotte A.
Smith-Warner S.A.
van den Brandt P.A.
Ziegler R.G.
Wang M.
Hou T.
Li R.
Adami H.-O.
Agnoli C.
Bernstein L.
Buring J.E.
Chen Y.
Connor A.E.
Eliassen A.H.
Genkinger J.M.
Gierach G.
Giles G.G.
Goodman G.G.
Hakansson N.
Krogh V.
Le Marchand L.
Lee I.-M.
Liao L.M.
Martinez M.E.
Miller A.B.
Milne R.L.
Neuhouser M.L.
Patel A.V.
Prizment A.
Robien K.
نوع الوثيقة: Electronic Resource
مستخلص: Associations between anthropometric factors and breast cancer (BC) risk have varied inconsistently by estrogen and/or progesterone receptor (ER/PR) status. Associations between prediagnostic anthropometric factors and risk of premenopausal and postmenopausal BC overall and ER/PR status subtypes were investigated in a pooled analysis of 20 prospective cohorts, including 36,297 BC cases among 1,061,915 women, using multivariable Cox regression analyses, controlling for reproductive factors, diet and other risk factors. We estimated dose-response relationships and tested for nonlinear associations using restricted cubic splines. Height showed positive, linear associations for premenopausal and postmenopausal BC risk (6-7% RR increase per 5 cm increment), with stronger associations for receptor-positive subtypes. Body mass index (BMI) at cohort baseline was strongly inversely associated with premenopausal BC risk, and strongly positively-and nonlinearly-associated with postmenopausal BC (especially among women who never used hormone replacement therapy). This was primarily observed for receptor-positive subtypes. Early adult BMI (at 18-20 years) showed inverse, linear associations for premenopausal and postmenopausal BC risk (21% and 11% RR decrease per 5 kg/m2, respectively) with stronger associations for receptor-negative subtypes. Adult weight gain since 18-20 years was positively associated with postmenopausal BC risk, stronger for receptor-positive subtypes, and among women who were leaner in early adulthood. Women heavier in early adulthood generally had reduced premenopausal BC risk, independent of later weight gain. Positive associations between height, baseline (adult) BMI, adult weight gain and postmenopausal BC risk were substantially stronger for hormone receptor-positive versus negative subtypes. Premenopausal BC risk was positively associated with height, but inversely with baseline BMI and weight gain (mostly in receptor-positive subtypes). Inverse associ
مصطلحات الفهرس: follow up, adult, aged, article, body height, body mass, body size, body weight change, body weight gain, body weight loss, breast cancer, cancer risk, controlled study, female, hormone substitution, human, menopause, meta analysis, postmenopause, premenopause, very elderly, young adult, estrogen receptor/ec [Endogenous Compound], hormone receptor/ec [Endogenous Compound], progesterone receptor/ec [Endogenous Compound], Article
URL: European Journal of Epidemiology
Click here for full text options
LibKey Link
الإتاحة: Open access content. Open access content
Copyright 2021 Elsevier B.V., All rights reserved.
أرقام أخرى: AUSHL oai:repository.monashhealth.org:1/26857
European Journal of Epidemiology. 36 (1) (pp 37-55), 2021. Date of Publication: January 2021.
0393-2990
https://repository.monashhealth.org/monashhealthjspui/handle/1/26857
Monash Health
van den Brandt, Piet A.; ORCID: http://orcid.org/0000-0001-8781-8099
33128203 [http://www.ncbi.nlm.nih.gov/pubmed/?term=33128203]
2007119752
(van den Brandt, Schouten) Department of Epidemiology, GROW - School for Oncology and Developmental Biology, Maastricht University, PO Box 616, Maastricht 6200 MD, Netherlands (van den Brandt) Department of Epidemiology, Care and Public Health Institute (CAPHRI), Maastricht University, PO Box 616, Maastricht 6200 MD, Netherlands (Ziegler, Gierach, Liao, Sinha, Stolzenberg-Solomon) Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States (Wang, Buring, Eliassen, Lee, Willett, Smith-Warner) Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States (Wang) Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, United States (Wang, Eliassen, Willett) Channing Division of Network Medicine, Department of Medicine, Harvard Medical School, Boston, MA, United States (Hou, Li, Willett, Smith-Warner) Department of Nutrition, Harvard T.H Chan School of Public Health, Boston, MA, United States (Adami) Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (Adami) Clinical Effectiveness Group, Institute of Health, University of Oslo, Oslo, Norway (Agnoli, Krogh) Epidemiology and Prevention Unit, Department of Research, Fondazione Istituto Nazionale Tumori, Milan 20133, Italy (Bernstein) Department of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, United States (Buring, Lee) Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States (Chen, Zeleniuch-Jacquotte) Division of Epidemiology, Department of Population Health and Department of Environmental Medicine, New York University School of Medicine, New York, United States (Connor, Visvanathan) Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States (Genkinger) Department of Epidemiology, Columbia University Mailman School o
van den Brandt P.A.; PA.vandenBrandt@maastrichtuniversity.nl
(van den Brandt, Schouten) Department of Epidemiology, GROW - School for Oncology and Developmental Biology, Maastricht University, PO Box 616, Maastricht 6200 MD, Netherlands
(van den Brandt) Department of Epidemiology, Care and Public Health Institute (CAPHRI), Maastricht University, PO Box 616, Maastricht 6200 MD, Netherlands
(Ziegler, Gierach, Liao, Sinha, Stolzenberg-Solomon) Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States
(Wang, Buring, Eliassen, Lee, Willett, Smith-Warner) Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States
(Wang) Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, United States
(Wang, Eliassen, Willett) Channing Division of Network Medicine, Department of Medicine, Harvard Medical School, Boston, MA, United States
(Hou, Li, Willett, Smith-Warner) Department of Nutrition, Harvard T.H Chan School of Public Health, Boston, MA, United States
(Adami) Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
(Adami) Clinical Effectiveness Group, Institute of Health, University of Oslo, Oslo, Norway
(Agnoli, Krogh) Epidemiology and Prevention Unit, Department of Research, Fondazione Istituto Nazionale Tumori, Milan 20133, Italy
(Bernstein) Department of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, United States
(Buring, Lee) Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States
(Chen, Zeleniuch-Jacquotte) Division of Epidemiology, Department of Population Health and Department of Environmental Medicine, New York University School of Medicine, New York, United States
(Connor, Visvanathan) Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
(Genkinger) Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, United States
(Genkinger) Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, United States
(Giles, Milne) Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia
(Giles, Milne) Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia
(Goodman, Neuhouser) Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
(Hakansson, Wolk) Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
(Le Marchand, White) Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, United States
(Martinez) Department of Family Medicine and Public Health School of Medicine, University of California San Diego, La Jolla, CA, United States
(Martinez) Moores Cancer Center, University of California San Diego, La Jolla, CA, United States
(Miller) Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
(Patel, Teras) Epidemiology Research Program, American Cancer Society, Atlanta, GA, United States
(Prizment) Division of Hematology, Oncology and Transplantation, University of Minnesota Medical School, Minneapolis, MN, United States
(Prizment) Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, United States
(Robien) Department of Exercise and Nutrition Sciences, Milken Institute School of Public Health, George Washington University, Washington, DC, United States
(Rohan) Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, United States
(Sawada, Tsugane) Epidemiology and Prevention Group, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan
(Weiderpass) International Agency for Research on Cancer, World Health Organization, Lyon, France
(Wolk) Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
(Giles, Milne) Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia
1305138284
المصدر المساهم: MONASH HEALTH LIBRS
From OAIster®, provided by the OCLC Cooperative.
رقم الأكسشن: edsoai.on1305138284
قاعدة البيانات: OAIster
الوصف
الوصف غير متاح.